0 participants
89Zr-Trastuzumab PET/CT in Subjects With Previously Treated HER2-Positive Solid Tumors Scheduled to Receive Treatment With MT-5111
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2021-12-23
- Start Date:
- 2021-12-31
- Completion:
- 2023-12-31
Conditions
- HER2-positive Solid Tumor
- HER-2 Positive Cancer
Interventions
- DRUG
No Results Yet